Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which iron dose do Moms-to-Be prefer? new study aims to find out

NCT ID NCT06069869

Knowledge-focused Sponsor: George Washington University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well pregnant women in Tanzania like and tolerate different amounts of iron in their daily prenatal vitamins. 156 women will try three different iron doses (30 mg, 45 mg, and 60 mg) and report which one they prefer and any side effects. The goal is to find the best iron dose that women are most likely to take regularly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 156 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Attending first ANC visit at the study clinic * Pregnant women ≤ 15 weeks of gestation * Aged ≥ 18 years * Intending to stay in Dar es Salaam for the duration of study * Provides informed consent Exclusion Criteria: * Severe anemia (defined as Hb \<8.5 g/dL per Tanzania standard of care) * Sickle cell disease (SS,SC, CC genotype) as tested by HemoTypeSC * Concurrent participation in other nutritional supplementation trial * Pregnant women with disability or condition which would impair their ability to provide informed consent and complete study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy related are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnancy related

Contacts and locations

Locations

  • Muhimbili University of Health and Allied Sciences

    Dar es Salaam, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.